Type V-K CAST System
Site-specific integration of therapeutic transgenes (e.g., Factor VIII for Hemophilia)
PreclinicalActive
Key Facts
Indication
Site-specific integration of therapeutic transgenes (e.g., Factor VIII for Hemophilia)
Phase
Preclinical
Status
Active
Company
About Metagenomi
Metagenomi is pioneering a new era of genetic medicine by harnessing the vast diversity of microbial life through metagenomics to discover and engineer next-generation genome editing tools. Founded by pioneers in the field, the company has built an industry-leading database, identified over 20,000 editing systems, and is advancing a pipeline of in vivo therapies for genetic diseases. With a strong leadership team, strategic partnerships, and a public listing, Metagenomi is positioned to expand its therapeutic reach and translate its novel platform into transformative patient cures.
View full company profile